Michael Hamilton has a broad practice with experience representing public and private clients across various industries in a diverse range of corporate and transactional matters, including capital markets transactions, SEC reporting obligations, governance matters and M&A transactions.
Hamilton’s capital markets experience includes advising on IPOs, secondary offerings, “shelf” offerings, “at-the-market” offerings and Rule 144A offerings, as well as private placement transactions, tender offers, exchange offers, consent solicitations, redomestications, and other corporate reorganization and liability management transactions.
He also has substantial experience in advising public companies on disclosure requirements, employment compensation matters, stock exchange requirements, and other corporate and securities representations. In addition, Hamilton represents public and private clients in M&A-related matters, including advising on capital structure and acquisition financing transactions.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2027 Lawdragon 500 Leading Dealmakers | 2027 | Capital Markets |
| The 2026 Lawdragon 500 Leading Dealmakers in America | 2026 | Capital Markets |
Hamilton’s significant representations include:
- Pfizer Inc. and its subsidiary Pfizer Investment Enterprises Pte. Ltd. in Pfizer Investment’s $31 billion offering of notes in eight tranches
- FedEx Corporation in its debt-for-debt exchange offers and consent solicitations to amend the terms of approximately $16 billion worth of notes across 22 tranches
- BlackRock, Inc.:
- in connection with its $12.5 billion acquisition of Global Infrastructure Partners, including its offerings of $500 million of 4.7% notes due 2029, $1 billion of 5% notes due 2034 and $1.5 billion of 5.25% notes due 2054
- in connection with its proposed $12 billion acquisition of HPS Investment Partners
- Royal Caribbean Cruises Ltd. in numerous transactions, including its offerings of $1 billion of 9.25% senior notes due 2029, $1 billion of 8.25% senior secured notes due 2029, $700 million of 7.25% senior notes due 2030 and $1.25 billion of 6.25% senior notes due 2032
- Performance Food Group Company in financing matters related to its acquisition of Cheney Bros, Inc., including its offering of $1 billion of 6.125% senior notes due 2032
- NXP Semiconductors N.V. in the establishment of a $2 billion commercial paper program
- Elon Musk in connection with financing matters related to his $44 billion acquisition of Twitter, and Twitter in connection with financing matters
Hamilton’s noted representations prior to joining Skadden include:
- a digital health care company in its $3.8 billion merger with a special purpose acquisition company (SPAC)
- a NYSE-listed chemicals company in its $2.5 billion acquisition by a strategic purchaser
- a NYSE-listed manufacturer and aftermarket service provider of flow control systems in its public offering of senior unsecured notes worth €500 million
- a NYSE-listed RV manufacturer in a $2.85 billion debt financing (consisting of a $2.1 billion term loan facility and a $750 million secured asset based loan facility) in connection with an acquisition